Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.sandu.in | |
Market Cap | 52.21 Cr. | |
Enterprise Value(EV) | 46.10 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.57 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 34.32 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 30.76 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 1.76 | Calculated using Price: 54.04 |
Dividend Yield | 1.39 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.97 Cr. | 9,660,990 Shares |
FaceValue | 10 | |
Company Profile | ||
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets. |
1 Day |
|
-1.40% |
1 Week |
|
-2.75% |
1 Month |
|
-12.13% |
3 Month |
|
-18.68% |
6 Month |
|
-22.47% |
1 Year |
|
-19.28% |
2 Year |
|
+50.53% |
5 Year |
|
+87.97% |
10 Year |
|
+348.84% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.76 | 2.28 | 2.92 | -2.44 | 3.09 | 3.53 | 3.66 | 5.03 | 6.29 | |
Return on Capital Employed (%) | 6.93 | 6.80 | 7.65 | 5.30 | 7.06 | 7.58 | 5.79 | 7.87 | 9.35 | |
Return on Assets (%) | 1.41 | 1.06 | 1.30 | -1.01 | 1.23 | 1.52 | 1.69 | 2.47 | 3.30 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 18 | 18 | 19 | 27 | 28 | 29 | 29 | 33 | 36 | 38 | |
Non Curr. Liab. | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Curr. Liab. | 16 | 21 | 21 | 18 | 15 | 14 | 11 | 13 | 12 | 13 | |
Minority Int. | |||||||||||
Equity & Liab. | 37 | 42 | 41 | 46 | 45 | 44 | 41 | 47 | 49 | 52 | |
Non Curr. Assets | 10 | 9 | 9 | 18 | 24 | 24 | 19 | 16 | 26 | 26 | |
Curr. Assets | 27 | 32 | 33 | 28 | 21 | 20 | 22 | 31 | 24 | 26 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 37 | 42 | 41 | 46 | 45 | 44 | 41 | 47 | 49 | 52 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 36 | 40 | 41 | 43 | 49 | 49 | 48 | 59 | 66 | 62 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |
Total Income | 36 | 40 | 41 | 43 | 49 | 50 | 49 | 59 | 66 | 62 | |
Total Expenditure | -34 | -37 | -38 | -41 | -47 | -47 | -47 | -57 | -63 | -59 | |
PBIDT | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 3 | 3 | |
Interest | -1 | -1 | -2 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | -1 | 0 | 0 | 0 | -1 | -1 | -1 | |
Exceptional Items | 0 | ||||||||||
PAT | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | |
Adjusted EPS | 1 | 1 | 1 | -1 | 1 | 1 | 1 | 1 | 2 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 5 | -1 | 5 | -1 | 5 | 1 | 4 | 6 | 8 | 1 | |
Cash Fr. Inv. | -2 | -1 | 0 | 0 | -1 | -1 | 0 | 0 | -6 | -5 | |
Cash Fr. Finan. | 0 | 0 | -2 | -2 | -2 | -2 | -4 | -5 | 1 | 1 | |
Net Change | 3 | -2 | 3 | -3 | 2 | -1 | -1 | 0 | 3 | -4 | |
Cash & Cash Eqvt | 3 | 1 | 4 | 1 | 3 | 1 | 1 | 1 | 5 | 1 |
Thu, 23 Mar 2023
Closure of Trading Window Closure of Trading Window for Q ended 31st March 2023 |
Sat, 18 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Stop Transfer for Duplicate issue of Share Certificate NALINI MAHENDRA PARAKH |
Tue, 14 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of loss of certificate certificate of AJAY PANDURANG KENI |
Fri, 24 Mar 2023 |
|
|
|
|
|